BSF Enterprise

BSFA:LNLondon Stock Exchange

Overview

Company Profile

BSF Enterprise is unlocking the next generation of biotech solutions through an acquisition-led growth strategy to drive the development of lab-grown tissues. Cell-based tissue engineering can be used to generate cultured meat, lab-grown leather, human corneas, collagen growth and skin substitutes. This technology will contribute to a radical transformation of the delivery of sustainable solutions across a variety of sectors.

Classification

SectorHealthcare
ExchangeLondon Stock Exchange
IndustryBiotechnology & Life Sciences